The cancer immunotherapy environment may confound the utility of anti-TIF-1Î³ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature.

Zarkavelis, George; Mauri, Davide; Karassa, Fotini; Eleftherios, Kampletsas; Pentheroudakis, George; Pappadaki, Alexandra; Mavroeidis, Leonidas; Ntellas, Panagiotis; Gkoura, Stefania; Gazouli, Ioanna

Zarkavelis, George; Mauri, Davide; Karassa, Fotini; Eleftherios, Kampletsas; Pentheroudakis, George; Pappadaki, Alexandra; Mavroeidis, Leonidas; Ntellas, Panagiotis; Gkoura, Stefania; Gazouli, Ioanna.

Afiliação

Zarkavelis G; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Mauri D; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Karassa F; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Eleftherios K; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Pentheroudakis G; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Pappadaki A; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Mavroeidis L; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Ntellas P; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Gkoura S; Department of Medical Oncology, University Hospital of Ioannina, Greece.
Gazouli I; Department of Medical Oncology, University Hospital of Ioannina, Greece.